Skip to main navigation Skip to search Skip to main content

Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial

  • Barry J. Plant
  • , Gisli G. Einarsson
  • , Kevin F. Deasy
  • , Darren Dahly
  • , Pradeep K. Singh
  • , Peter J. Barry
  • , Christopher H. Goss
  • , Isabelle Fajac
  • , Tamara Vagg
  • , Isabelle Durieu
  • , Evelyn Flanagan
  • , Grace O’Callaghan
  • , Clémence Martin
  • , Pierre Régis Burgel
  • , Charles S. Haworth
  • , R. Andres Floto
  • , Damian G. Downey
  • , Lieven J. Dupont
  • , Andrew M. Jones
  • , J. Stuart Elborn
  • Joseph A. Eustace, Marcus A. Mall, Michael M. Tunney
  • Queen's University Belfast
  • University of Washington
  • Manchester University NHS Foundation Trust
  • University of Manchester
  • Université Paris Cité
  • Institut Cochin
  • CF Core Network
  • Hospices civils de Lyon
  • Universite Claude Bernard Lyon 1
  • Assistance publique – Hôpitaux de Paris
  • University of Cambridge
  • Royal Papworth Hospital NHS Foundation Trust
  • KU Leuven
  • Charité – Universitätsmedizin Berlin
  • German Center for Lung Research (DZL)
  • Berlin Institute of Health

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology